
Modern Retina Spring 2023


The sharing of data between ophthalmologists and optometrists ultimately can lead to earlier diagnosis and better results for patients.

Imaging biomarkers are useful to determine the degree of EZ attenuation in the fovea.

Industry leaders look at what’s in the therapeutic delivery pipeline for these disorders.

Physicians should consider hydrodynamic cavitation when performing this procedure.

Examining an intraocular implant that can sharpen vision for patients as disease progresses.

Advertisement
Advertisement
Trending on Eye Care Network - Ophthalmology Times
1
Retina Society 2026: MCO-010 optogenetic therapy maintains visual acuity gains through 4 years in advanced RP
2
Retina Society 2026: Medium-dose OCU410 gene therapy cuts geographic atrophy progression by up to 32% in phase 2 trial
3
Retina Society 2026: LUGANO secondary data show reduced treatment burden with vorolanib insert despite missed primary end point
4
Beyond the phenotype: Aqueous humor sampling moves retinoblastoma toward personalized therapy
5
